Terns Pharmaceuticals, Inc.TERNNASDAQ
Loading
Current Ratio Over TimeFair Value
Percentile Rank50
3Y CAGR-1.9%
5Y CAGR+38.8%
Studio
Year-over-Year Change

Current ratio (current assets / current liabilities)

3Y CAGR
-1.9%/yr
Annual compound
5Y CAGR
+38.8%/yr
Recent deceleration
Percentile
P50
Within normal range
vs 5Y Ago
5.2x
Strong expansion
Streak
1 yr
Consecutive growthFair Value
PeriodValueYoY Change
202423.14+3.3%
202322.39-33.5%
202233.68+37.6%
202124.48+514.7%
20203.98-11.3%
20194.49-87.9%
201837.25-